From C-reactive protein to interleukin-6 to interleukin-1: moving upstream to identify novel targets for atheroprotection
PM Ridker - Circulation research, 2016 - Am Heart Assoc
Plasma levels of the inflammatory biomarker high-sensitivity C-reactive protein (hsCRP)
predict vascular risk with an effect estimate as large as that of total or high-density …
predict vascular risk with an effect estimate as large as that of total or high-density …
[HTML][HTML] Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
Inflammation occurs as a result of exposure of tissues and organs to harmful stimuli such as
microbial pathogens, irritants, or toxic cellular components. The primary physical …
microbial pathogens, irritants, or toxic cellular components. The primary physical …
The role of interleukin-1 in general pathology
N Kaneko, M Kurata, T Yamamoto, S Morikawa… - Inflammation and …, 2019 - Springer
Abstract Interleukin-1, an inflammatory cytokine, is considered to have diverse physiological
functions and pathological significances and play an important role in health and disease. In …
functions and pathological significances and play an important role in health and disease. In …
[HTML][HTML] NLRP3 inflammasome: from a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases
A Abderrazak, T Syrovets, D Couchie, K El Hadri… - Redox biology, 2015 - Elsevier
IL-1β production is critically regulated by cytosolic molecular complexes, termed
inflammasomes. Different inflammasome complexes have been described to date. While all …
inflammasomes. Different inflammasome complexes have been described to date. While all …
Caspase functions in cell death and disease
DR McIlwain, T Berger, TW Mak - Cold Spring Harbor …, 2013 - cshperspectives.cshlp.org
Caspases are a family of endoproteases that provide critical links in cell regulatory networks
controlling inflammation and cell death. The activation of these enzymes is tightly controlled …
controlling inflammation and cell death. The activation of these enzymes is tightly controlled …
The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response
A Baroja-Mazo, F Martín-Sánchez, AI Gomez… - Nature …, 2014 - nature.com
Assembly of the NLRP3 inflammasome activates caspase-1 and mediates the processing
and release of the leaderless cytokine IL-1β and thereby serves a central role in the …
and release of the leaderless cytokine IL-1β and thereby serves a central role in the …
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
CA Dinarello, A Simon… - Nature reviews Drug …, 2012 - nature.com
Abstract Interleukin-1 (IL-1) is a highly active pro-inflammatory cytokine that lowers pain
thresholds and damages tissues. Monotherapy blocking IL-1 activity in autoinflammatory …
thresholds and damages tissues. Monotherapy blocking IL-1 activity in autoinflammatory …
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
CA Dinarello - Blood, The Journal of the American Society of …, 2011 - ashpublications.org
More than any other cytokine family, the IL-1 family of ligands and receptors is primarily
associated with acute and chronic inflammation. The cytosolic segment of each IL-1 receptor …
associated with acute and chronic inflammation. The cytosolic segment of each IL-1 receptor …
Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives
The inflammasome is a molecular platform formed by activation of an innate immune pattern
recognition receptor seed, such as NLRP3. Once activated, NLRP3 recruits the adapter ASC …
recognition receptor seed, such as NLRP3. Once activated, NLRP3 recruits the adapter ASC …
Treating inflammation by blocking interleukin-1 in humans
CA Dinarello, JWM van der Meer - Seminars in immunology, 2013 - Elsevier
IL-1 is a master cytokine of local and systemic inflammation. With the availability of specific
IL-1 targeting therapies, a broadening list of diseases has revealed the pathologic role of IL …
IL-1 targeting therapies, a broadening list of diseases has revealed the pathologic role of IL …